Fidelity International
PROF

Fidelity International’s Profound Medical PROF Stock Holding History

Fidelity International’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.8M Buy
2,370,000
+30,000
+1% +$202K 0.01% 535
2026
Q1 		$15.2M Buy
2,340,000
+140,000
+6% +$967K 0.01% 532
2025
Q4 		$17.3M Buy
2,200,000
+315,000
+17% +$2.02M 0.01% 499
2025
Q3 		$9.39M Hold
1,885,000
– – 0.01% 580
2025
Q2 		$11.1M Buy
1,885,000
+70,000
+4% +$370K 0.01% 531
2025
Q1 		$10.6M Buy
1,815,000
+20,000
+1% +$138K 0.01% 520
2024
Q4 		$13.5M Buy
1,795,000
+260,000
+17% +$2M 0.01% 504
2024
Q3 		$12.2M Buy
1,535,000
+30,000
+2% +$271K 0.01% 532
2024
Q2 		$12.7M Buy
1,505,000
+154,365
+11% +$1.24M 0.01% 495
2024
Q1 		$11.3M Buy
1,350,635
+150,000
+12% +$1.25M 0.01% 508
2023
Q4 		$10.1M Hold
1,200,635
– – 0.01% 504
2023
Q3 		$12M Hold
1,200,635
– – 0.01% 472
2023
Q2 		$15.4M Buy
1,200,635
+13,010
+1% +$161K 0.02% 441
2023
Q1 		$11M Sell
1,187,625
-38,050
-3% -$440K 0.01% 477
2022
Q4 		$13.1M Buy
1,225,675
+120,290
+11% +$656K 0.02% 456
2022
Q3 		$4.47M Buy
1,105,385
+15,000
+1% +$101K 0.01% 589
2022
Q2 		$7.96M Buy
1,090,385
+25,010
+2% +$198K 0.01% 531
2022
Q1 		$9.59M Buy
1,065,375
+40,000
+4% +$385K 0.01% 540
2021
Q4 		$11.6M Buy
1,025,375
+25,000
+2% +$312K 0.01% 522
2021
Q3 		$14.6M Buy
1,000,375
+125,030
+14% +$1.9M 0.02% 484
2021
Q2 		$14.3M Buy
875,345
+50,010
+6% +$930K 0.02% 502
2021
Q1 		$16.6M Sell
825,335
-200,025
-20% -$4.8M 0.02% 464
2020
Q4 		$21.1M Sell
1,025,360
-100,010
-9% -$1.84M 0.03% 400
2020
Q3 		$19.8M Buy
1,125,370
+229,950
+26% +$3.65M 0.02% 397
2020
Q2 		$15.2M Buy
895,420
+29,995
+3% +$379K 0.02% 421
2020
Q1 		$8.33M Sell
865,425
-110,200
-11% -$1.43M 0.01% 476
2019
Q4 		$11.1M Buy
+975,625
New +$8.99M 0.02% 488

Other funds holding PROF

GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
RMC
Ring Mountain Capital Tiburon, California $238M AUM 61.63% 1-Year Est. Return

Fidelity International's PROF Position: Q2 2026 in Review

Fidelity International increased its Profound Medical (PROF) stake by 1.3% in Q2 2026, buying an estimated $202K and bringing the position to 2,370,000 shares worth $15.8M. The position accounts for 0.01% of the portfolio, ranked #535.

Fidelity International first reported a position in PROF in Q4 2019 and has held it in 27 quarters since. The position peaked at $21.1M in Q4 2020. 56 funds tracked by Wall St. Rank hold PROF as of Q2 2026.

  • Fidelity International held 2,370,000 shares of Profound Medical worth $15.8M as of Q2 2026.
  • Fidelity International bought 30,000 Profound Medical shares in Q2 2026, an estimated $202K.
  • Profound Medical made up 0.01% of Fidelity International's portfolio in Q2 2026, its #535 holding.
  • Fidelity International first reported a position in Profound Medical in Q4 2019 and has held it in 27 quarters since.
  • Fidelity International's Profound Medical position peaked at $21.1M in Q4 2020.
  • 56 funds tracked by Wall St. Rank held Profound Medical as of Q2 2026.

Based on Fidelity International's 13F filing for Q2 2026, filed 13 Aug 2026.